In this retrospective study of AKI following acute pancreatitis, the authors identify risk factors associated with mortality. These findings provide a basis for focussing on high risk patients for future trials of therapeutic interventions.
Acute kidney injury (AKI) is any abrupt impairment (within 48 h) of renal function and structure from any cause and is characterized by the rapid loss of the kidney's excretory function. It is typically diagnosed by the accumulation of end products of nitrogen metabolism (urea and creatinine) or decreased urine output, or both. Commonly associated with high morbidity and mortality, AKI is often secondary to extrarenal events and familiar multifactorial etiology. 1, 2 Severe acute pancreatitis (SAP), an acute abdominal disease with unpredictable clinical courses, is an important precursor of AKI and drastically increases the disease burden. 3 For example, SAP leads to an incidence of AKI as high as 54% among critically ill patients. 4 Previous literature has also revealed a 10-fold increase in mortality among critically ill SAP-induced AKI patients. 5, 6 However, SAP-induced AKI is greatly understudied, as the clinical characteristics and underlying processes of AKI coexisting with SAP are still elusive. Moreover, there are few clinical studies on etiologies and outcomes of SAP-induced AKI, especially among those receiving intensive care. Of particular interest is the fact that, even in the Kidney Disease: Improving Global Outcomes (KDIGO) summary reviewed by Kellum and Lameire, SAP was not mentioned as a cause of AKI. 7 Since 2005, the Acute Kidney Injury Network (AKIN) has advocated several important changes in the AKI criteria. For example, the time constraint of diagnosis for AKI was introduced to ensure that the process was acute and representative of events within a clinically relevant time period, and the use of RRT was added as a criterion for AKI III. Some studies have indicated that the AKIN criteria could improve the sensitivity of AKI diagnosis. [8] [9] [10] [11] [12] [13] [14] However, to our knowledge, only one study with 50 SAP-induced AKI patients applied the AKIN criteria. 4 To address the knowledge gap, we plan to use the AKIN criteria to define and classify AKI following SAP onset and describe the clinical characteristics and laboratory results in intensive care. The paper describes the epidemiology of AKI with SAP under the AKIN criteria. Leveraging a relatively large cohort of critically ill patients, we aim to explore the severity of illness by using various scoring systems, investigate risk factors associated with the development of AKI, and describe the overall prognosis of this cohort.
METHODS

Study protocol
This was a retrospective and multi-center analysis of a database collected from a large cohort study of critically ill patients admitted to five ICU centers due to SAP in the time period between August 2009 to June 2013. Requirement for approval by the local ethics committee and the need for informed consent were waived because the retrospective study required neither therapeutic or prophylactic intervention nor contravention of privacy or confidentiality.
Study population
All patients who were over 18 years old and admitted to the ICU with evidence of SAP were eligible. However, patients who were treated with renal replacement therapy (RRT) within the past month or were on dialysis at ICU admission and had received kidney transplant were excluded.
Data collection
Patients' age, sex, laboratory data, clinical details, including the aetiology of SAP, AKIN classification, disease history, presence of comorbidity, and partial treatment, were collected in the database. The primary outcomes were documented as the ICU-length-of-stay (ICU-LOS) and mortality in ICU. The predictive role of two general severity of illness scoring systems (Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment (SOFA) scores) and two disease-specific scoring systems (Computed Tomography Severity Index (CTSI) and Ranson scores) were calculated using the worst values obtained in the first 48 h after admission to ICU. Partial treatments such as operations, RRT, mechanical ventilation, vasopressor use and diuretics were considered. The highest number of failed organs involved (except kidney) during the ICU stay was summarized and recorded as 'maximum number of associated failed organ systems' for each patient.
Definition
In our study, AKI is defined as an absolute increase in serum creatinine of greater than or equal to 0.3 mg/dL (≥26.4 μmol/L) and a percentage increase in serum creatinine of greater than or equal to 50% (1.5-fold from baseline) within 48 h. We define the lowest value of serum creatinine measured within 2 days prior to ICU admission as the baseline creatinine value. If no serum creatinine was available, we considered the first creatinine available within 2 days after ICU admission as the baseline serum creatinine values. AKI is classified as AKI stage I, II, or III, according to the patient's level of serum creatinine ( Table 1 ). As 6-and 12-hourly urine volumes were largely missing in the database, we used creatinine to define and classify AKI and compare it with subsequent values every 2 days until death or discharge from ICU. The highest AKI stage during patients' ICU stay defines the final AKI classification. SAP, as proposed by Bradley, known as the Atlanta classification, is established by either an APACHE II score >8, Ranson score >3, the presence of more than one organ failure, or local complications. 15 Sepsis was defined as the presence of positive blood cultures accompanied by systemic inflammatory response syndrome (SIRS). 16 
Statistical analysis
In our descriptive analysis, continuous variables are described as mean ± standard deviations (SD) and 95% confidence intervals (CI Table 2 . Table 3 shows an increasing linear trend with percentages of 29.0% for AKI I, 39.5% for AKI II, and 56.6% for AKI III. Figure 1 depicts serum creatinine level trend in non-AKI and AKI groups during their ICU stay. A comparison of the basic characteristics and laboratory variables between SAP patients with and without AKI are listed in Table 3 . The proportions of chronic kidney disease (CKD), sepsis, and ACS are significantly higher in the AKI group than in the non-AKI group (P < 0.05). A number of factors are associated with significant differences between AKI I, II, and III patients in Table 3 (P < 0.05). Patients with AKI are mostly older and have higher baseline serum creatinine, blood urea nitrogen (BUN), Cystain-C, and C-reactive protein (CRP) levels when compared with patients without AKI (P < 0.05). However, there was no significant difference between having AKI and not having AKI in the aetiology, and also no significant difference among AKI I, II, and III patients. Meanwhile, ICU-LOS was not a significant risk factor and did not distinguish patients who developed AKI and those who did not (Table 3) . We next performed a multiple logistic regression on these 287 SAP-induced AKI patients to identify the effect of the independent risk factors on ICU mortality. Our univariate analysis identified that ICU-LOS, AKIN stage, SIRS, sepsis, hypoproteinaemia, ACS, ARDS, ALI, and maximum number of associated organ failures were significant risk factors. The APACHE II score and CTSI are higher in non-survivors (Table 4) . However, there are no significant differences in age, CKD, Ranson and SOFA score (P > 0.05) between both groups. The results of multivariate logistic regression analysis are shown in (Table 5) .
DISCUSSION
Despite significant progress in the management of patient treatment, such as early enteral nutrition, decompression surgery, and RRT, SAP remains a severe medical condition with multi-organ failure and a poor clinical prognosis, especially in critically ill patients. 23 We conducted a retrospective analysis of ICU patients, validated the ability of the AKIN criteria to evaluate the occurrence of AKI in SAP patients, and assessed risk factors for ICU mortality.
Our results suggest that AKI patients experience a significantly higher ICU mortality compared with those who never develop AKI during intensive care (20.5% vs 44.9%, P < 0.001), which is consistent with published reports. 24, 25 The mortality in the AKI III group is the highest at 55.6% compared with the AKI I and II groups. Moreover, more advanced AKIN classifications are associated with higher rates of ICU mortality, in an approximately linear fashion. Our analysis demonstrates that AKI is more common among older patients and the incidence of ACS increases as the AKI stage increases (Table 3 ). In our study, heart failure rate and CRP level were higher in the non-AKI group than in the AKI group. Both results were surprising, compared to many other reports on AKI. Possible reasons include differences in the populations characteristics studied, and different criteria in the diagnosis of AKI, for example, RIFLE criteria or KDIGO criteria. In addition, SAP is a dysregulated inflammatory AKI following severe acute pancreatitis response to infection and it can lead to multiple-organ dysfunction syndrome in the end. The CRP level cannot completely reflect systemic inflammation in critically ill patients. Our analysis has identified several factors as predictors for ICU mortality. ICU-LOS, AKI III (using AKI I as the reference classification), sepsis, ACS, CTSI, APACHE II score, RRT, and multiple failed organ systems (using one failed organ system as the reference classification) are the primary and independent factors for mortality in this cohort. Patients with a history of renal disease who develop SAP have a significant risk factor for developing AKI, but it is not an independent prognostic factor, in contradiction with some studies. 5, 24, 26 Meanwhile, our conclusion that the type of treatment, except for RRT, is not independently associated with ICU mortality also contrasts with studies that focused on other types of nephrology. 12, [27] [28] [29] Several studies have asserted that renal failure is always one of the main drivers in multi-organ failure due to SAP. 23, 30 The main pathophysiology is initiated as an uncontrolled systemic inflammatory process with ensuing hypovolaemia, either from wide-spread vasodilation or fluid sequestration, and reduced tissue perfusion, which ultimately causes organ damage and failure, even multi-organ failure. 24 We show that multi-organ failure is an important prognostic factor in SAP induced-AKI as reported previously. 5, 31, 32 Sepsis is a highly prevalent syndrome characterized by a whole-body inflammatory state and the presence of a known or suspected infection that has severe consequences, including multi-organ failure. 10 Previous reports have suggested that AKI is frequently considered to be a serious complication of sepsis in ICU patients and that septic AKI effects an important and independent increase in the risk for hospital death. 10, 27, 33 In our study, the prevalence of sepsis as a complication of SAP was 21.7%. AKI occurred in 75.6% (68/90) of all critically ill patients with both SAP and sepsis. In multivariate logistic regression analysis, the sepsis showed an ICU mortality odds ratio of 2.46 (P < 0.001). The findings of our study confirm and largely extend a previous investigation. 34 There are several different scoring systems aimed at estimating the prognosis of patients with SAP. 20, [35] [36] [37] [38] The APACHE II and the SOFA scores are general severity of illness scoring systems that are positively correlated with SAP severity and have good prognostic value. 35, 37, 39 The Ranson scores are the most commonly used and the CTSI has been shown to have good predictive value. 20, 38 However, in our original study, we find only that CTSI and APACHE II scores were significant risk factors for AKI in patients with SAP, at variance with previous studies. An adequately powered validation study is necessary to evaluate the role of the various scores in the AKI cohort following SAP onset.
Limitations
There are, however, some limitations in our study. First, the diagnosis of SAP was made partly at the discretion of individual investigators. Second, due to lack of exact and complete urine volumes, we had to resort to serum creatinine levels obtained in the relevant period. As a result, we may have underestimated patients who only fulfilled the AKI criteria on urine output and, perhaps, underestimated the incidence of AKI. Third, there is no cause-effect relationship between ICU stay and development of AKI that can be drawn in this cross-sectional study, but we have verified risk factors that may be associated with AKI in the hospital or ICU settings as in previous research. Finally, as no data on long-term follow-up were available beyond the ICU discharge, patients' long-term mortality and renal conditions remain unknown.
Conclusion
Few epidemiological studies have been conducted on the SAP-induced AKI patients cohorts. The results of the present research suggest that the AKIN criteria might offer sensitive diagnostic measures among SAP patients. We have found that ACS, RRT, sepsis, CTSI, APACHE II score, AKI III, ICU-LOS, and multi-organ failure are significant risk factors associated with high ICU mortality among the SAP-induced AKI patients. Our findings have the potential to lead to effective therapeutic measures to prevent and manage SAP-induced AKI, with the ultimate goal of improving survival outcomes among critically ill patients.
